[NVIC] HPV Vaccine Increases Cancer Risk

[Guest guest]

E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER

Vienna, Virginia http://www.nvic.org

* * * * * * * * * * * * * * * * * * * * * * *

UNITED WAY/COMBINED FEDERAL CAMPAIGN

#8122

* * * * * * * * * * * * * * * * * * * * * * *

" Protecting the health and informed consent rights of children since 1982. "

============================================================================

==============

BL Fisher Note:

Gardasil, the heavily promoted cervical cancer and genital wart vaccine

that Merck, the CDC and AAP want to mandate for all 11 and 12 year old

girls, will not only increase the risk of cervical cancer for some of

adolescent girls but can also make them susceptible to infection from the

multiple other strains of HPV. In addition, five women who got the vaccine

around time of conception gave birth to babies with birth defects.

With American babies now getting 48 doses of 14 vaccines by age six,

profit-hungry drug companies and power-hungry federal health officials are

targeting adolescents for new vaccine consumption. During a time when

adolescents are undergoing hormonal changes and accelerated growth, they are

being subjected to increased atypical manipulation of the immune system with

viral and bacterial vaccines including DTaP, meningococcal, flu, hepatitis B

and now a genital wart and cervical cancer vaccine.

In this national experiment on our teenagers, will anybody be studying

onset of chronic disease and disability in adolescents post vaccination? Or

will predictable increases in brain and immune system dysfunction such as

onset of new allergies, asthma, seizure disorders, multiple sclerosis,

rheumatoid arthritis, diabetes, irritable bowel syndrome, thyroid disease,

chronic fatigue, depression, and yes, cancer, be written off as unassociated

with vaccination?

Injecting adolescent girls with any vaccine that could increase their

chance of getting cancer without their voluntary, informed consent and the

consent of their parents is immoral. All attempts to mandate Gardasil for

school entry should be opposed as a violation of human rights, including the

right to life.

http://www.washingtonpost.com/wp-dyn/content/article/2006/05/17/AR2006051700

931.html?sub=AR

The Washington Post

FDA: Cervical cancer vaccine safe

Gardasil prevents four types of HPV

Wednesday, May 17, 2006

WASHINGTON (AP) -- A vaccine that blocks infection by the four virus types

that cause most cervical cancers and genital warts appears safe and

effective, but may actually increase the chance of disease in some patients,

according to Food and Drug Administration documents released Wednesday.

Merck & Co. seeks FDA approval for its Gardasil vaccine against four types

of human papilloma virus, or HPV. Two of those four types are believed

responsible for about 70 percent of cervical cancer cases. The cancer kills

roughly 3,500 U.S. women a year; the other two types cause 90 percent of

genital wart cases.

An FDA panel of outside experts is to meet Thursday and discuss whether to

recommend that the agency approve the vaccine. The FDA isn't required to

follow the advice of its expert panels but usually does.

According to briefing documents released ahead of the meeting, the panel

should discuss various items of concern only if its members first agree that

studies show the vaccine is safe and effective. That suggests the FDA favors

its approval.

Merck said the vaccine has the potential to reduce the annual number of new

cervical cancers worldwide to roughly 150,000, from the current 500,000, and

cut global deaths from the cancer by more than two-thirds, to an estimated

90,000.

An FDA review of the results of studies on the vaccine found two important

concerns, according to the documents released ahead of Thursday's meeting of

the Vaccines and Related Biological Products advisory committee.

The first is that the vaccine may lead to an increased number of cases of a

cancer precursor among patients already infected by any of the four virus

types at the time they receive the vaccine, and whose immune systems have

not cleared the virus from their bodies.

The second concern is that any advantage the vaccine provides in protecting

against the four virus types could be offset by infection by any of the

multiple other types of HPV that the vaccine does not cover, according to

the FDA documents.

FDA staff also asked that the committee examine five cases where children

with birth defects were born to women who had received the vaccine around

the time of conception.

Merck developed the vaccine and tested it in both women and men, but

Thursday's discussion is expected to focus on its use in preventing

HPV-related disease in women.

An FDA decision is expected by June 8. Should it approve it, the national

Advisory Committee on Immunization Practices will decide later that month

whether to endorse routine vaccination with the vaccine.

The committee's HPV vaccine workgroup is recommending the vaccine be given

to girls 11 and 12, and the committee will consider recommendations for

females 13 to 26.

=============================================

News@... is a free service of the National Vaccine Information

Center and is supported through membership donations. Learn more about

vaccines, diseases and how to protect your informed consent rights

http://www.nvic.org

Become a member and support NVIC's work

https://www.nvic.org/making%20cash%20donations.htm

To sign up for a free e-mail subscription http://www.nvic.org/emaillist.htm